{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:24:56Z","timestamp":1794939896838,"version":"4.9.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,14]]},"abstract":"<jats:p>This study analyzes the burden of Alzheimer disease and other dementias (ADOD) in China using Global Burden of Disease 2021 data. The data on ADOD in China from 1990 to 2021 was collected from the Global Burden of Disease 2021. The incidence rate, mortality and the number of disability adjusted life years (DALYs), and age-standardized rates of ADOD were analyzed. Use Joinpoint analysis to evaluate trends. Analyze the attribution ratio of risk factors such as smoking, high body mass index, and high fasting blood glucose (FPG) to the burden of ADOD disease. Evaluate the relative contributions of epidemiological changes, population growth, and population aging through decomposition analysis. Autoregressive Integrated Moving Average model is used to evaluate future trends. Age-standardized incidence rose from 121.11 (95% confidence interval: 105.5\u2013137.99) to 151.47 (131.22\u2013173.34) per 100,000, with an estimated annual percentage change (APC) of 0.41% (0.34\u20130.49%). Age-standardized mortality declined from 31.39 (7.6\u201383.63) to 30.82 (7.88\u201382.43) per 100,000, yet deaths increased by 3.92% annually (estimated APC: 3.79\u20134.04%). disability adjusted life years (DALYs) surged to 10.07 (4.95\u201322.22) million, with age-standardized DALY rate reaching 562.39 (271.16\u20131238.81) per 100,000. Joinpoint regression confirmed upward trends for age-standardized incidence (average APC\u2005=\u20050.60%, 0.46\u20130.74%) and age-standardized DALY rate (average APC\u2005=\u20050.10%, \u22120.01 to 0.22%). The incidence rate, mortality, and DALYs of ADOD in men and women mostly occur in the age group over 75 years old. FPG was the leading risk factor, attributing to 10.5% of DALYs, followed by smoking (8.0%) and high body mass index (0.2%). Decomposition analysis identified epidemiological changes as the primary driver of mortality increases (679,000 deaths, 45.6% contribution), exceeding aging (595,000 deaths) and population growth (214,000 deaths). Projections to 2036 indicate dramatic growth: cases rising to 7.46 (5.73\u20139.20) million, deaths to 1.12 (0.93\u20131.31) million, and DALYs to 23.76 (19.10\u201328.43) million. The ADOD burden in China has significantly increased, especially among women and the elderly population. It is worth noting that FPG is the primary risk factor for ADOD. The disease ADOD burden will continue to rise. Attention should be paid to the issue of population aging, and interventions targeting ADOD risk factors should be emphasized.<\/jats:p>","DOI":"10.1097\/md.0000000000045880","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:01:31Z","timestamp":1763154091000},"page":"e45880","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiological trends, attributable risks, decomposition analysis, and forecasts of Alzheimer\u2019s disease and other dementias burden in China, 1990 to 2036: A population-based observational study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6006-6975","authenticated-orcid":false,"given":"Haigang","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital of Henan Medical University, Weihui City, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251121","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer\u2019s disease facts and figures.","volume":"20","year":"2024","journal-title":"Alzheimers Dement"},{"key":"R2-20251121","first-page":"344","article-title":"GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"23","year":"2024","journal-title":"Lancet Neurol"},{"key":"R3-20251121","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jalz.2017.12.006","article-title":"The cost of Alzheimer\u2019s disease in China and re-estimation of costs worldwide.","volume":"14","author":"Jia","year":"2018","journal-title":"Alzheimers Dement"},{"key":"R4-20251121","doi-asserted-by":"crossref","first-page":"e100751","DOI":"10.1136\/gpsych-2022-100751","article-title":"The China Alzheimer Report 2022.","volume":"35","author":"Ren","year":"2022","journal-title":"Gen Psychiatr"},{"key":"R5-20251121","doi-asserted-by":"crossref","first-page":"709156","DOI":"10.3389\/fnagi.2021.709156","article-title":"Secular trends in the incidence of and mortality due to Alzheimer\u2019s disease and other forms of dementia in China from 1990 to 2019: an age-period-cohort study and Joinpoint analysis.","volume":"13","author":"Gao","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"R6-20251121","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"R7-20251121","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1002\/alz.14254","article-title":"Temporal trend and attributable risk factors of Alzheimer\u2019s disease and other dementias burden in China: Findings from the Global Burden of Disease Study 2021.","volume":"20","author":"Yang","year":"2024","journal-title":"Alzheimers Dement"},{"key":"R8-20251121","doi-asserted-by":"crossref","first-page":"102557","DOI":"10.1016\/j.jiph.2024.102557","article-title":"Global burden and incidence trends of zika virus infection among women aged 15\u201349 years from 2011 to 2021: a systematic analysis.","volume":"17","author":"Qin","year":"2024","journal-title":"J Infect Public Health"},{"key":"R9-20251121","doi-asserted-by":"crossref","first-page":"1425577","DOI":"10.3389\/fnagi.2024.1425577","article-title":"Time trends in Alzheimer\u2019s disease mortality attributable to metabolic risks and smoking in China from 1990 to 2019: an age-period-cohort analysis.","volume":"16","author":"Sun","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"R10-20251121","doi-asserted-by":"crossref","first-page":"taae069","DOI":"10.1093\/jtm\/taae069","article-title":"Discrepancies in dengue burden estimates: a comparative analysis of reported cases and global burden of disease study, 2010\u20132019.","volume":"31","author":"Lee","year":"2024","journal-title":"J Travel Med"},{"key":"R11-20251121","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"key":"R12-20251121","doi-asserted-by":"crossref","first-page":"e16199","DOI":"10.1111\/liv.16199","article-title":"Global burden, trends, and inequalities of gallbladder and biliary tract cancer, 1990\u20132021: a decomposition and age-period-cohort analysis.","volume":"45","author":"Lei","year":"2025","journal-title":"Liver Int"},{"key":"R13-20251121","doi-asserted-by":"crossref","first-page":"140","DOI":"10.18332\/tid\/191389","article-title":"Disease burden and related risk factors of esophageal cancer in China and globally from 1990 to 2021, with forecast to 2035: an analysis and comparison.","volume":"22","author":"Wang","year":"2024","journal-title":"Tob Induc Dis"},{"key":"R14-20251121","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1212\/WNL.0000000000013115","article-title":"Global, regional, and national burden of ischemic stroke, 1990\u20132019.","volume":"98","author":"Ding","year":"2022","journal-title":"Neurology"},{"key":"R15-20251121","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1016\/S2468-2667(20)30185-7","article-title":"Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study.","volume":"5","author":"Jia","year":"2020","journal-title":"Lancet Public Health"},{"key":"R16-20251121","doi-asserted-by":"crossref","first-page":"29","DOI":"10.14283\/jpad.2019.41","article-title":"Multidomain interventions to prevent cognitive impairment, Alzheimer\u2019s disease, and dementia: from FINGER to world-wide FINGERS.","volume":"7","author":"Rosenberg","year":"2020","journal-title":"J Prev Alzheimers Dis"},{"key":"R17-20251121","doi-asserted-by":"crossref","first-page":"1575906","DOI":"10.3389\/fpubh.2025.1575906","article-title":"A GBD 2021 study of Alzheimer\u2019s disease and other dementias attributable to metabolic risk factors and forecasts to 2045 in China.","volume":"13","author":"Zhu","year":"2025","journal-title":"Front Public Health"},{"key":"R18-20251121","doi-asserted-by":"crossref","first-page":"680","DOI":"10.15585\/mmwr.mm7120a2","article-title":"Modifiable risk factors for Alzheimer disease and related dementias among adults aged \u226545 years \u2013 United States, 2019.","volume":"71","author":"Omura","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R19-20251121","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuint.2019.02.006","article-title":"Molecular mechanisms for nicotine intoxication.","volume":"125","author":"Alkam","year":"2019","journal-title":"Neurochem Int"},{"key":"R20-20251121","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1212\/WNL.53.9.1992","article-title":"Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. EURODEM Incidence Research Group.","volume":"53","author":"Andersen","year":"1999","journal-title":"Neurology"},{"key":"R21-20251121","doi-asserted-by":"crossref","first-page":"e209298","DOI":"10.1212\/WNL.0000000000209298","article-title":"Associations between age at menopause, vascular risk, and 3-year cognitive change in the Canadian Longitudinal Study on aging.","volume":"102","author":"Wood Alexander","year":"2024","journal-title":"Neurology"},{"key":"R22-20251121","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-8587(21)00269-2","article-title":"Management of menopause: a view towards prevention.","volume":"10","author":"Lobo","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R23-20251121","doi-asserted-by":"crossref","first-page":"101542","DOI":"10.1016\/j.arr.2021.101542","article-title":"A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer\u2019s prevention & treatment.","volume":"74","author":"Mishra","year":"2022","journal-title":"Ageing Res Rev"},{"key":"R24-20251121","doi-asserted-by":"crossref","first-page":"100122","DOI":"10.1016\/j.tjpad.2025.100122","article-title":"The disease burden, risk factors and future predictions of Alzheimer\u2019s disease and other types of dementia in Asia from 1990 to 2021.","volume":"12","author":"Guo","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"R25-20251121","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"R26-20251121","doi-asserted-by":"crossref","first-page":"e0210621","DOI":"10.1371\/journal.pone.0210621","article-title":"The temporal trend and distribution characteristics in mortality of Alzheimer\u2019s disease and other forms of dementia in China: based on the National Mortality Surveillance System (NMS) from 2009 to 2015.","volume":"14","author":"Bo","year":"2019","journal-title":"PLoS One"},{"key":"R27-20251121","first-page":"101106","article-title":"Temporal trends and disparities of population attributable fractions of modifiable risk factors for dementia in China: a time-series study of the China health and retirement longitudinal study (2011\u20132018).","volume":"47","author":"Chen","year":"2024","journal-title":"Lancet Reg Health West Pac"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:03:02Z","timestamp":1763766182000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":27,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045880","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"2025-07-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}